Distribution of VGF peptides in the human cortex and their selective changes in Parkinson's and Alzheimer's diseases

Journal of Anatomy

Volumn 217, Issue 6, 2010, Pages 683-693

  Cocco, Cristina ^a   D'Amato, Filomena ^a   Noli, Barbara ^a   Ledda, Antonella ^a   Brancia, Carla ^a   Bongioanni, Paolo ^b   Ferri, Gian Luca ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Alzheimer's disease; Human cortex; Parkinson's disease; VGF peptides

Indexed keywords

NEUROENDOCRINE REGULATORY PEPTIDE 1; PEPTIDE; PROTEIN ANTIBODY; PROTEIN PRECURSOR; PROVGF PROTEIN; REGULATOR PROTEIN; UNCLASSIFIED DRUG; VGF PEPTIDE;

ADULT; AGED; ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BRAIN CORTEX; BRAIN NERVE CELL; BRAIN TISSUE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FRONTAL CORTEX; GEL CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; MALE; MOLECULAR MECHANICS; MOLECULAR WEIGHT; NEUROPATHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PARIETAL LOBE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; TEMPORAL CORTEX;

ALZHEIMER DISEASE; ANIMALS; CADAVER; CATTLE; CEREBRAL CORTEX; ENZYME-LINKED IMMUNOSORBENT ASSAY; GUINEA PIGS; HUMANS; IMMUNOHISTOCHEMISTRY; NERVE TISSUE PROTEINS; NEUROPEPTIDES; PARKINSON DISEASE; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; RABBITS; RATS; RNA, MESSENGER;

BOVINAE; RATTUS;

EID: 78349235456     PISSN: 00218782     EISSN: 14697580     Source Type: Journal    
DOI: 10.1111/j.1469-7580.2010.01309.x     Document Type: Article

References (37)

1. Alder J, Thakker-Varia S, Bangasser DA, et al. (2003) Brain-derived neurotrophic factor-induced gene expression reveals novel actions of VGF in hippocampal synaptic plasticity. J Neurosci 34, 10800-10808.
2. Bozdagi O, Rich E, Tronel S, et al. (2008) The neurotrophin-inducible gene Vgf regulates hippocampal function and behavior through a brain-derived neurotrophic factor-dependent mechanism. J Neurosci 28, 9857-9869.
3. Brancia C, Nicolussi P, Cappai P, et al. (2005) Differential expression and seasonal modulation of VGF peptides in sheep pituitary. J Endocrinol 186, 97-107.
4. B receptors in scopolamine-induced amnesia. J Neurochem 6, 1978-1989.
5. Canu N, Possenti R, Ricco AS, et al. (1997) Cloning, structural organization analysis, and chromosomal assignment of the human gene for the neurosecretory protein VGF. Genomics 45, 443-446.
6. Carrette O, Demalte I, Scherl A, et al. (2003) A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease. Proteomics 8, 1486-1494.
7. Cattaneo A, Sesta A, Calabrese F, et al. (2010) The expression of VGF is reduced in leukocytes of depressed patients and is restored by effective antidepressant treatment. Neuropsychopharmacology 103, 2010-2011.
8. Cocco C, Melis GV, Ferri GL (2003) Embedding media for cryomicrotome: an applicative reppraisal. Appl Immunohistochem Mol Morphol 11, 274-280.
9. Cocco C, Brancia C, Pirisi I, et al. (2007) VGF metabolic-related gene: distribution of its derived peptides in mammalian pancreatic islets. J Histochem Cytochem 55, 619-628.
10. Conti F, Aldo R, Peter P, et al. (1987) Glutamate-positive neurons in the somatic sensory cortex of rats and monkeys. J Neurosci 7, 1887-1901.
11. D'Amato F, Noli B, Brancia C, et al. (2008) Differential distribution of VGF-derived peptides in the adrenal medulla and evidence for their selective modulation. J Endocrinol 197, 359-369.
12. Fahnestock M, Garzon D, Holsinger RM, et al. (2002) Neurotrophic factors and Alzheimer's disease: are we focusing on the wrong molecule? J Neural Transm Suppl 62, 241-252.
13. Ferri GL, Gaudio RM, Cossu M, et al. (1995) The "VGF" protein in rat adenohypophysis: sex differences and changes during the estrous cycle and after gonadectomy. Endocrinology 136, 2244-2251.
14. Foundas AL, Leonard CM, Mahoney SM, et al. (1997) Atrophy of the hippocampus, parietal cortex, and insula in Alzheimer's disease: a volumetric magnetic resonance imaging study. Neuropsychiatry Neuropsychol Behav Neurol 10, 81-89.
15. Haung JT, Leweke FM, Oxley D, et al. (2006) Disease biomarkers in cerebrospinal fluid of patients with first-onset. PLoS Med 3, 428.
16. Hunsberger JG, Newton SS, Bennett AH, et al. (2007) Antidepressant actions of the exercise-regulated gene VGF. Nat Med 13, 1476-1482.
17. Levi A, Ferri GL, Watson E, et al. (2004) Processing, distribution, and function of VGF, a neuronal and endocrine peptide precursor. Cell Mol Neurobiol 24, 517-533.
18. Liu J-W, Andrews PC, Mershon JL, et al. (1994) Peptive V: a VGF-derived neuropeptide purified from bovine posterior pituitary. Endocrinology 135, 2742-2748.
19. Mahata M, Hortnagl H, Mahata SK, et al. (1993) Messengers RNA levels of chromogranin B, secretogranin II, and VGF in rat brain after AF 64A-induced septohippocampal cholinergic lesions. J Neurochem 61, 1648-1656.
20. Pandya DN, Yeterian EH (1985) Architecture and connection of cortical association areas. Cereb Cortex 4, 3-61.
21. Pasinetti GM, Ungar LH, Lange DJ, et al. (2006) Identification of potential CSF biomarkers in ALS. Neurology 66, 1.
22. Playford ED, Jenkins IH, Passingham RE, et al. (1992) Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study. Ann Neurol 32, 151-161.
23. Possenti R, Eldridge JD, Paterson BM, et al. (1989) A protein induced by NGF in PC 12 cells is stored in secretory vesicles and release through the regulated pathway. EMBO J 8, 2217-2223.
24. Possenti R, Rinaldi AM, Ferri GL, et al. (1999) Expression, processing, and secretion of the neuroendocrine VGF peptides by INS-1 cells. Endocrinology 140, 3727-3735.
25. Rindi G, Licini L, Necchi V, et al. (2007) Peptide products of the neurotrophin-inducible gene vgf are produced in human neuroendocrine cells from early development and increase in hyperplasia and neoplasia. J Clin Endocrinol Metab 92, 2811-2815.
26. Ruetschi U, Zetterberga H, Podustd VN, et al. (2005) Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF. Exp Neurol 196, 273-281.
27. Salton SRJ, Ferri GL, Hahm S, et al. (2000) VGF: a novel role for this neuronal and neuroendocrine polypeptide in the regulation of energy balance. Front Neuroendocrinol 21, 199-219.
28. Samuel M, Ceballos-Baumann AO, Blin J, et al. (1997) Evidence for lateral premotor and parietal overactivity in Parkinson's disease during sequential and bimanual movements A PET study. Brain 120, 963-976.
29. Selle H, Lamerz J, Buerger K, et al. (2005) Identification of novel biomarker candidates by differential peptidomics analysis of cerebrospinal fluid in Alzheimer's disease. Comb Chem High Throughput Screen 8, 801-806.
30. Snyder SE, Li J, Salton SR (1997) Comparison of VGF and trk mRNA distributions in the developing and adult rat nervous systems. Brain Res Mol Brain Res 49, 307-311.
31. Snyder SE, Cheng HV, Murray KD, et al. (1998) The messenger RNA encoding VGF, a neuronal peptide precursor, is rapidly regulated in the rat central nervous system by neuronal activity seizure and lesion. Neuroscience 828, 7-19.
32. Thakker VS, Alder J (2009) Neuropeptides in depression: role of VGF. Behav Brain Res 197, 262-278.
33. Toshinai K, Nakazato M (2009) Neuroendocrine regulatory peptide-1 and -2: novel bioactive peptides processed from VGF. Cell Mol Life Sci 66, 1939-1945.
34. Trani E, Ciotti T, Rinaldi AM, et al. (1995) Tissue-specific processing of the neuroendocrine protein VGF. J Neurochem 65, 2441-2449.
35. Trani E, Giorni A, Canu N, et al. (2002) Isolation and characterization of VGF peptides in rat brain. Role of PC1/3 and PC2 in the maturation of VGF precursor. J Neurochem 81, 565-574.
36. Ukmar M, Furlan C, Moretti R, et al. (2005) Functional MRI in the assessment of cortical activation in subjects with Parkinson's disease. Neuroradiology 111, 104-105.
37. Yamaguchi H, Sasaki K, Satomi Y, et al. (2007) Peptidomic identification and biological validation of neuroendocrine regulatory peptide-1 and -2. J Biol Chem 282, 26354-26360.